findmyKOL
Clinical trialNCT04609904CompletedPhase 3Interventional

Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (LOGOS)

SponsorAstraZenecaEnrollment2,187Asthma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

317 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Brazil
  • Research Site

    Botucatu, Brazil

  • Research Site

    Porto Alegre, Brazil

  • Research Site

    Porto Alegre, Brazil

  • Research Site

    Porto Alegre, Brazil

  • Research Site

    Porto Alegre, Brazil

  • Research Site

    Santo André, Brazil

  • Research Site

    Sorocaba, Brazil

  • Research Site

    São Paulo, Brazil

China
  • Research Site

    Baotou, China

  • Research Site

    Beijing, China

  • Research Site

    Changsha, China

  • Research Site

    Changsha, China

  • Research Site

    Changsha, China

  • Research Site

    Changzhi, China

  • Research Site

    Chengdu, China

  • Research Site

    Chengdu, China

  • Research Site

    Chizhou, China

  • Research Site

    Chongqing, China

  • Research Site

    Chongqing, China

  • Research Site

    Dongguan, China

  • Research Site

    Dongyang, China

  • Research Site

    Fuzhou, China

  • Research Site

    Guangzhou, China

  • Research Site

    Guangzhou, China

  • Research Site

    Guangzhou, China

  • Research Site

    Guangzhou, China

  • Research Site

    Guangzhou, China

  • Research Site

    Guangzhou, China

  • Research Site

    Haikou, China

  • Research Site

    Haikou, China

  • Research Site

    Hangzhou, China

  • Research Site

    Hangzhou, China

  • Research Site

    Hefei, China

  • Research Site

    Hefei, China

  • Research Site

    Hefei, China

  • Research Site

    Huai'an, China

  • Research Site

    Huizhou, China

  • Research Site

    Jinan, China

  • Research Site

    Jinhua, China

  • Research Site

    Kunming, China

277 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 Mar 2021
Primary completion
20 Mar 2025
Completion
20 Mar 2025
Last update posted
2 Jul 2026
Registered enrollment
2,187
Registry id
NCT04609904

Cross-registrations

EU-CTR / CTIS (EudraCT)2020-001521-31EU-CTR / CTIS (EudraCT)2023-505786-88

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.